| Structured crowdsourcing enables convolutional segmentation of histology images M Amgad, H Elfandy, H Hussein, LA Atteya, MAT Elsebaie, LS Abo Elnasr, ... Bioinformatics 35 (18), 3461-3467, 2019 | 187 | 2019 |
| Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta‐analysis MAT Elsebaie, N van Es, A Langston, HR Büller, M Gaddh Journal of Thrombosis and Haemostasis 17 (4), 645-656, 2019 | 109 | 2019 |
| NuCLS: A scalable crowdsourcing approach and dataset for nucleus classification and segmentation in breast cancer M Amgad, LA Atteya, H Hussein, KH Mohammed, E Hafiz, MAT Elsebaie, ... GigaScience 11, giac037, 2022 | 73 | 2022 |
| Management of low and intermediate risk adult rhabdomyosarcoma: a pooled survival analysis of 553 patients MAT Elsebaie, M Amgad, A Elkashash, AS Elgebaly, GGE Ashal, E Shash, ... Scientific reports 8 (1), 9337, 2018 | 22 | 2018 |
| Explainable nucleus classification using decision tree approximation of learned embeddings M Amgad, LA Atteya, H Hussein, KH Mohammed, E Hafiz, MAT Elsebaie, ... Bioinformatics 38 (2), 513-519, 2022 | 12 | 2022 |
| Is fertility-preservation safe for adult non-metastatic gynecologic rhabdomyosarcoma patients? Systematic review and pooled survival analysis of 137 patients MAT Elsebaie, Z Elsayed Archives of Gynecology and Obstetrics 297, 559-572, 2018 | 11 | 2018 |
| A population-level digital histologic biomarker for enhanced prognosis of invasive breast cancer M Amgad, JM Hodge, MAT Elsebaie, C Bodelon, S Puvanesarajah, ... Nature Medicine 30 (1), 85-97, 2024 | 8 | 2024 |
| Clinical utilization and cost of thrombophilia testing in patients with venous thromboembolism M Gaddh, E Cheng, MAT Elsebaie, I Bodó TH Open 4 (03), e153-e162, 2020 | 7 | 2020 |
| Severe multiorgan toxicity after first dose of Capizzi methotrexate in a young adult patient with acute lymphocytic leukaemia EG Caldito, JM Pescatore, M Elsebaie BMJ Case Reports CP 14 (7), e243153, 2021 | 3 | 2021 |
| Predictors of Survival among Early Onset Pancreatic Adenocarcinoma Patients A Tertiary Care Center Experience. AM Alkashash, MA Elsebaie, MH Bikhet, M Morsi, RK Paluri Chirurgia (Bucharest, Romania: 1990) 116 (1), 24-33, 2021 | 3 | 2021 |
| Therapie des antiphospholipid-syndroms (APS) mit DOAKs R Bauersachs, S Schellong, M Stücker, J Oldenburg, C Kalka, U Scholz, ... Hämostaseologie 39 (03), 298-300, 2019 | 3 | 2019 |
| Comparative analysis of direct oral anticoagulants and vitamin K antagonists in antiphospholipid syndrome patients MAT Elsebaie, ZA Wickham, S Debragga, J Li, M Gaddh Blood 138, 2135, 2021 | 2 | 2021 |
| Follow‐up to comment on “Direct Oral Anticoagulants in Patients with Venous Thromboembolism and Thrombophilia: Systematic Review and Meta‐Analysis” MAT Elsebaie, N Van Es, A Langston, HR Büller, M Gaddh Journal of Thrombosis and Haemostasis 17 (6), 1007-1009, 2019 | 2 | 2019 |
| A population-level computational histologic signature for invasive breast cancer prognosis M Amgad, J Hodge, M Elsebaie, C Bodelon, S Puvanesarajah, D Gutman, ... Research Square, 2023 | 1 | 2023 |
| Does High-Dose Thromboprophylaxis Improve Outcomes in COVID-19 Patients? A Meta-analysis of Comparative Studies MAT Elsebaie, B Baral, M Elsebaie, T Shrivastava, C Weir, D Kumi, ... TH Open 6 (04), e323-e334, 2022 | 1 | 2022 |
| Clinical outcomes of prophylactic vs. Therapeutic doses of anticoagulation in COVID-19 Patients: A systematic reviewand meta-analysis MA Elsebaie, B Baral, T Shrivastava, MJ Tariq, D Kumi, M Elsebaie Research and Practice in Thrombosis and Haemostasis, 2021 | 1 | 2021 |
| A step toward genomic equity: Mutational profiling of patients with myeloid neoplasm in the largest minority-serving hospital in metropolitan Chicago. MAT Elsebaie, E Turk, V Deenadayalan, K Obeidat, A Nanaa, M Zia, ... Journal of Clinical Oncology 41 (16_suppl), 7037-7037, 2023 | | 2023 |
| Epidemiologic effectors on the breast tumor microenvironment: Results from the Cancer Prevention Study-II and-3 cohorts. MAT Elsebaie, M Amgad, JM Hodge, MM Gaudet, LR Teras, AN Shah, ... Journal of Clinical Oncology 41 (16_suppl), 10530-10530, 2023 | | 2023 |
| TH Open MA Elsebaie, B Baral, M Elsebaie, T Shrivastava, C Weir, D Kumi, N Birch | | 2022 |
| Thirty day readmissions and outcomes following radical nephrectomy in renal cell carcinoma: A nationwide analysis. T Shrivastava, M Salazar, V Prado, E Gauto, B Baral, S Upadhyay, ... Journal of Clinical Oncology 39 (15_suppl), e16560-e16560, 2021 | | 2021 |
Mohamed Amgad TageldinDept. of Pathology, Northwestern UniversityVerified email at northwestern.edu
